Daily BriefsEquity Bottom-Up

Daily Brief Equity Bottom-Up: 2024 High Conviction: VinFast (VFS US) – Heading for Trouble and more

In today’s briefing:

  • 2024 High Conviction: VinFast (VFS US) – Heading for Trouble
  • 2024 High Conviction: Long BYD and Short Tesla
  • China Healthcare Weekly (Nov.24) – Gold Content Of License-Out Deals, NRDL Pricing Levels, CR Sanjiu
  • Tongcheng Travel (780 HK): Rides on the Tourism Upswing
  • China Consumption Weekly (27 Nov 2023): Trip.com, Xiaomi, IQiyi, Full Truck, Home Appliance Export


2024 High Conviction: VinFast (VFS US) – Heading for Trouble

By Arun George

  • Vinfast (VFS US), a Vietnamese EV manufacturer and a majority-owned affiliate of Vingroup Jsc (VIC VN), completed its merger with Black Spade on 14 August. 
  • Due to the low float, the shares have been on a wild ride, with the last close of US$6.56 materially below the high of US$82.35 per share.
  • VinFast remains an avoid due to related party-driven EV sales, declining customer traction, operating losses, cash burn, equity raise overhang and frothy valuation.  

2024 High Conviction: Long BYD and Short Tesla

By Henry Soediarko

  • Tesla Motors (TSLA US) market share in China has decreased and its 3Q23 operational data suggested it offered discounts to defend its market share. 
  • Albeit losing some market share, BYD (1211 HK) operational data is much more solid, even expanded its profit margin during a difficult environment in China. 
  • Tesla share price has outpaced BYD’s this year by 70%, it should reverse in the next year.

China Healthcare Weekly (Nov.24) – Gold Content Of License-Out Deals, NRDL Pricing Levels, CR Sanjiu

By Xinyao (Criss) Wang

  • It is the upfront payment rather than the total or subsequent milestone payments that indicates the gold content of license-out collaborations. We analyzed our criteria.
  • Investors actually don’t need to worry too much about the NRDL negotiation results, because the NRDL price of domestic innovative drugs has become relatively stable. There are basically three levels.
  • We analyzed key points about China Resources Sanju. Considering the impact of anti-corruption in 23Q3 and the weak performance of TCM formula granules business, 23H2 performance could be under pressure. 

Tongcheng Travel (780 HK): Rides on the Tourism Upswing

By Osbert Tang, CFA

  • Tongcheng Travel Holdings (780 HK) is best positioned to capture post-COVID travel, especially in lower-tier cities. This is reflected in a 146.5% growth in 3Q23 adjusted net profit.
  • The cooperation with Tencent (700 HK) continues to bear fruits and will drive accelerated momentum as it leverages on QQ Browser, Weixin mini-program, and Tencent Docs.
  • 3Q23 net cash increased 1.5x from the end-FY22 level and now represents 10.9% of market capitalisation. Its earnings valuations are attractive relative to both growth and peers.

China Consumption Weekly (27 Nov 2023): Trip.com, Xiaomi, IQiyi, Full Truck, Home Appliance Export

By Ming Lu

  • Trip.com’s domestic hotel bookings increased by 70% over pre-COVID 3Q19.
  • Xiaomi’s revenue began to grow in 3Q23 after decreasing for five quarters.
  • China home appliance export surged in October, for example, fridge export amount growing by 42% YoY.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars